With decades of expertise in continuous flow processing, support your project support ar every step, from development to commercialization, promising efficiency and sustainability.
Solve the unique challenges of poorly soluble molecules like targeted protein degraders (TPDs), such as PROTACs and molecular glues, seamlessly pushing your molecule to market.
We seek to treat your products as if they are our own, giving you access to the same expertise and state-of-the-art technologies that we use to deliver our breakthroughs.
Dr. David Rowe, Head of Manufacturing at Nanoform, provides an overview of Nanoform's manufacturing capabilities and introduces a new, state-of-the-art nanotechnology facility.
Delivering high-quality pharmaceutical and nutraceutical products through precise blending and encapsulation in cGMP-compliant facilities using gold-standard technology.
With expertise spanning development, scale-up, and manufacturing, our seasoned professionals stand ready to fulfill the requirements of small molecule API projects of any batch size.
Learn how a partner with comprehensive services can help you reduce development risks, shorten time to market, and navigate complex global regulations with ease.
From pre-clinical development through to market launch, we provide a seamless, end-to-end pathway under one roof, driven by unparalleled project management.
This platform, using on-demand cGMP manufacturing, integrates pharmaceutical development and clinical pharmacology, enabling rapid iterations based on real-time clinical data.
Reconstituted nasal epithelium (RNE) offers a human-relevant model for nasal drug delivery, outperforming frozen mucosa and aligning better with clinical outcomes for opioid formulations.
